{
  "title": "Effects of the insurmountable angiotensin AT receptor antagonist candesartan and the surmountable antagonist losartan on ischemia-reperfusion injury in rat hearts",
  "institution": "Astra Hassle, Sweden",
  "year": "1999",
  "key_findings": [
    {
      "conclusion": "Pre-treatment with candesartan 10nM or losartan 3mM immediately prior to ischemia improved the recovery of left ventricular developed pressure as compared to the effect of vehicle (69±3.2% and 64±2.3 vs. 44±6.2%, respectively; P<0.05).",
      "evidence": "Results from hearts subjected to 25 min of global ischemia and 45 min of reperfusion."
    },
    {
      "conclusion": "The cumulative creatine kinase release during the first 30 min of reperfusion in the washout experiments was lower in the candesartan group (28.5±2.30 U, P<0.05), but not in the losartan group (40.8±6.73 U), than in the vehicle group (48.1±4.35 U).",
      "evidence": "Data from the washout experiments after drug administration."
    }
  ],
  "applicable_situations": [
    {
      "situation": "Patients undergoing ischemia-reperfusion injury treatment",
      "advice": "Consider pre-treatment with candesartan or losartan to improve left ventricular developed pressure recovery and reduce creatine kinase release."
    },
    {
      "situation": "Research on angiotensin AT1 receptor antagonists",
      "advice": "Focus on the differences in cardioprotective effects between insurmountable and surmountable receptor antagonists."
    }
  ],
  "categories": [
    "Pharmacology",
    "Cardiology"
  ],
  "keywords": [
    "Angiotensin II",
    "Ischemia",
    "Reperfusion",
    "Myocardium",
    "Vasoconstriction"
  ]
}